|
bis(2-(Dimethylamino)ethyl)ether |
CAS 3033-62-3 | ||
C8H20N2O |
RTECS KR9460000 | ||
Synonyms & Trade Names NIAX® A99; NIAX® Catalyst A1; 2,2'-Oxybis(N,N-dimethyl ethylamine) [Note: A component (5%) of NIAX® Catalyst ESN, along with dimethylaminopropionitrile (95%).] |
DOT ID & Guide |
Exposure
|
NIOSH REL: See Appendix C (NIAX® Catalyst ESN) | ||
OSHA PEL: See Appendix C (NIAX® Catalyst ESN) | |||
IDLH N.D. See: IDLH INDEX | Conversion |
Physical Description Liquid. |
|||
MW: 160.3 |
BP: 372°F |
FRZ: ? |
Sol: ? |
VP: ? |
IP: ? |
|
Sp.Gr: ? |
Fl.P: ? |
UEL: ? |
LEL: ? |
|
Incompatibilities & Reactivities None reported |
Measurement Methods None available See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
Symptoms Possible urinary disturbance, neurological disorders; in animals: irritation eyes, skin | |
Target Organs
Eyes, skin, urinary tract, peripheral nervous system |
See also: INTRODUCTION |